See up to 3 months of PCVX. The 7-day demo opens the 1M and 3M ranges and puts PCVX on your watchlist.
Start 7-day demoLatest PCVX insider trades
About Vaxcyte, Inc. (PCVX)
The SEC lists Vaxcyte, Inc. under CIK 0001649094, in biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
PCVX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 21 | 92,890 | $6.32M |
| Grant or award | 2 | 140,886 | |
| Option exercise | 16 | 173,896 | |
PCVX insider transactions (Form 4)
7190 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Teri Loxam - Director | Grant or award | Stock Option (right to buy) | 11,389 | $0.00 | - | |
| Teri Loxam - Director | Grant or award | Common Stock | 2,265 footnote F1 | $0.00 | - | |
| ||||||
| Anne S. Drapeau - Director | Grant or award | Stock Option (right to buy) | 11,389 | $0.00 | - | |
| Anne S. Drapeau - Director | Grant or award | Common Stock | 2,265 footnote F1 | $0.00 | - | |
| ||||||
 Heath Lukatch - Director | Grant or award | Common Stock | 2,265 footnote F1 | $0.00 | - | |
| Heath Lukatch - Director | Grant or award | Stock Option (right to buy) | 11,389 | $0.00 | - | |
| ||||||
| Jim Wassil - Officer | Open-market sale | Common Stock | 1,949 | $49.40 footnote F2 | $96K | |
| Jim Wassil - Officer | Open-market sale | Common Stock | 301 | $50.26 footnote F3 | $15K | |
| ||||||
| Jim Wassil - Officer | Open-market sale | Common Stock | 2,250 | $56.83 footnote F2 | $128K | |
| ||||||
| Elvia Cowan - Officer | Option exercise | Common Stock | 3,000 | $25.92 | $78K | |
| Elvia Cowan - Officer | Open-market sale | Common Stock | 3,000 | $60.00 | $180K | |
| Elvia Cowan - Officer | Option exercise | Stock Option (right to buy) | 3,000 | $0.00 | - | |
| Jim Wassil - Officer | Open-market sale | Common Stock | 1,412 | $58.14 footnote F2 | $82K | |
| Jim Wassil - Officer | Open-market sale | Common Stock | 838 | $58.93 footnote F3 | $49K | |
| ||||||
| Elvia Cowan - Officer | Open-market sale | Common Stock | 1,487 | $55.39 footnote F2 | $82K | |
| Elvia Cowan - Officer | Open-market sale | Common Stock | 405 | $56.26 footnote F3 | $23K | |
| ||||||
| Harpreet S. Dhaliwal - Officer | Tax withholding / forfeiture | Common Stock | 604 footnote F1 | $59.32 | $36K | |
| ||||||
 Grant Pickering - Officer | Tax withholding / forfeiture | Common Stock | 3,685 footnote F1 | $59.32 | $219K | |
| ||||||
 Andrew Guggenhime - Officer | Tax withholding / forfeiture | Common Stock | 1,021 footnote F1 | $59.32 | $61K | |
| ||||||
| Elvia Cowan - Officer | Tax withholding / forfeiture | Common Stock | 495 footnote F1 | $59.32 | $29K | |
| Elvia Cowan - Officer | Open-market sale | Common Stock | 2,500 | $58.59 | $146K | |
| Elvia Cowan - Officer | Option exercise | Common Stock | 2,500 | $25.92 | $65K | |
| Elvia Cowan - Officer | Option exercise | Stock Option (right to buy) | 2,500 | $0.00 | - | |
| ||||||
| Jim Wassil - Officer | Tax withholding / forfeiture | Common Stock | 975 footnote F1 | $59.32 | $58K | |
| Jim Wassil - Officer | Open-market sale | Common Stock | 2,427 | $58.32 footnote F3 | $142K | |
| Jim Wassil - Officer | Open-market sale | Common Stock | 4,968 | $59.16 footnote F4 | $294K | |
| ||||||
| Elvia Cowan - Officer | Option exercise | Common Stock | 7,716 | $25.92 | $200K | |
| Elvia Cowan - Officer | Grant or award | Stock Option (right to buy) | 17,855 | $0.00 | - | |
| Elvia Cowan - Officer | Option exercise | Stock Option (right to buy) | 7,716 | $0.00 | - | |
| Elvia Cowan - Officer | Grant or award | Common Stock | 10,681 footnote F1 | $0.00 | - | |
| Elvia Cowan - Officer | Tax withholding / forfeiture | Common Stock | 243 footnote F2 | $61.98 | $15K | |
| Elvia Cowan - Officer | Tax withholding / forfeiture | Common Stock | 326 footnote F2 | $61.98 | $20K | |
| ||||||
| Andrew Guggenhime - Officer | Grant or award | Common Stock | 44,864 footnote F1 | $0.00 | - | |
| Andrew Guggenhime - Officer | Tax withholding / forfeiture | Common Stock | 898 footnote F2 | $61.98 | $56K | |
| Andrew Guggenhime - Officer | Tax withholding / forfeiture | Common Stock | 1,009 footnote F2 | $61.98 | $63K | |
| Andrew Guggenhime - Officer | Grant or award | Stock Option (right to buy) | 74,993 | $0.00 | - | |
| ||||||
| Grant Pickering - Officer | Grant or award | Common Stock | 105,110 footnote F1 | $0.00 | - | |
| Grant Pickering - Officer | Tax withholding / forfeiture | Common Stock | 2,863 footnote F2 | $61.98 | $177K | |
| Grant Pickering - Officer | Tax withholding / forfeiture | Common Stock | 2,531 footnote F2 | $61.98 | $157K | |
| Grant Pickering - Officer | Grant or award | Stock Option (right to buy) | 175,698 | $0.00 | - | |
| ||||||
| Harpreet S. Dhaliwal - Officer | Grant or award | Common Stock | 53,409 footnote F1 | $0.00 | - | |
| Harpreet S. Dhaliwal - Officer | Tax withholding / forfeiture | Common Stock | 292 footnote F2 | $61.98 | $18K | |
| Harpreet S. Dhaliwal - Officer | Tax withholding / forfeiture | Common Stock | 465 footnote F2 | $61.98 | $29K | |
| Harpreet S. Dhaliwal - Officer | Grant or award | Stock Option (right to buy) | 46,424 | $0.00 | - | |
| ||||||
| Jim Wassil - Officer | Grant or award | Common Stock | 32,045 footnote F1 | $0.00 | - | |
| Jim Wassil - Officer | Grant or award | Common Stock | 5,102 footnote F2 | $61.74 | $315K | |
| Jim Wassil - Officer | Tax withholding / forfeiture | Common Stock | 1,900 footnote F3 | $61.74 | $117K | |
| Jim Wassil - Officer | Tax withholding / forfeiture | Common Stock | 898 footnote F3 | $61.98 | $56K | |
| Jim Wassil - Officer | Tax withholding / forfeiture | Common Stock | 1,009 footnote F3 | $61.98 | $63K | |
| Jim Wassil - Officer | Grant or award | Stock Option (right to buy) | 53,566 | $0.00 | - | |
| ||||||
| Grant Pickering - Officer | Gift | Common Stock | 100,000 footnote F1 | $0.00 | - | |
| ||||||
| Andrew Guggenhime - Officer | Gift | Common Stock | 61,850 footnote F1 | $0.00 | - | |
| Andrew Guggenhime - Officer | Gift | Common Stock | 61,850 | $0.00 | - | |
| ||||||
| Olivier Brandicourt - Director | Grant or award | Common Stock | 1,357 | $0.00 | - | |
| Olivier Brandicourt - Director | Grant or award | Stock Option (right to buy) | 6,750 | $0.00 | - | |
| Jim Wassil - Officer | Tax withholding / forfeiture | Common Stock | 2,759 | $32.41 | $89K | |
| Elvia Cowan - Officer | Tax withholding / forfeiture | Common Stock | 482 | $32.41 | $16K | |
| Harpreet S. Dhaliwal - Officer | Tax withholding / forfeiture | Common Stock | 1,204 | $32.41 | $39K | |
| Grant Pickering - Officer | Tax withholding / forfeiture | Common Stock | 7,356 | $32.41 | $238K | |
| Andrew Guggenhime - Officer | Tax withholding / forfeiture | Common Stock | 2,890 | $32.41 | $94K | |
| Jim Wassil - Officer | Tax withholding / forfeiture | Common Stock | 1,270 | $31.56 | $40K | |
| Jim Wassil - Officer | Tax withholding / forfeiture | Common Stock | 1,587 | $31.56 | $50K | |
| Jim Wassil - Officer | Tax withholding / forfeiture | Common Stock | 1,429 | $31.56 | $45K | |
| Elvia Cowan - Officer | Tax withholding / forfeiture | Common Stock | 242 | $31.56 | $8K | |
| Elvia Cowan - Officer | Tax withholding / forfeiture | Common Stock | 325 | $31.56 | $10K | |
| Harpreet S. Dhaliwal - Officer | Tax withholding / forfeiture | Common Stock | 291 | $31.56 | $9K | |
| Harpreet S. Dhaliwal - Officer | Tax withholding / forfeiture | Common Stock | 783 | $31.56 | $25K | |
| Harpreet S. Dhaliwal - Officer | Tax withholding / forfeiture | Common Stock | 464 | $31.56 | $15K | |
| Grant Pickering - Officer | Tax withholding / forfeiture | Common Stock | 2,857 | $31.56 | $90K | |
| Grant Pickering - Officer | Tax withholding / forfeiture | Common Stock | 4,563 | $31.56 | $144K | |
| Grant Pickering - Officer | Tax withholding / forfeiture | Common Stock | 3,420 | $31.56 | $108K | |
Item 1.01, 2.03, 8.01, 9.01
Item 7.01, 8.01, 9.01
Item 5.02, 7.01, 9.01
Item 2.02, 9.01
Recent PCVX Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Cowan Elvia | Officer | 19,000 | $1.65M | View on EDGAR | |
| Wassil Jim | Officer | 18,000 |
Stock trades in PCVX disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
 Gilbert Ray Cisneros, Jr.Democrat, CA-31 | Purchase |
PCVX insider trading FAQ
What is the latest insider trade for PCVX?
Vaxcyte, Inc. (PCVX) had 18 insider filings in the last 90 days, with the most recent on 2026-10-07. The full record for PCVX runs to 90 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying PCVX stock?
No insider purchases of PCVX were filed in the last 90 days.
How many insiders are selling PCVX stock?
21 insider sales of PCVX were filed in the last 90 days, totaling $6.32M.
Where can I see PCVX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects PCVX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Jim Wassil view on EDGAR
- - Elvia Cowan view on EDGAR
- - Jim Wassil view on EDGAR
- - Grant Pickering view on EDGAR
- - Andrew Guggenhime view on EDGAR
- - Harpreet S. Dhaliwal view on EDGAR
- - Elvia Cowan view on EDGAR
- - Jim Wassil view on EDGAR
- - Luis Jodar view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where PCVX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow PCVX with a 7-day demo
- PCVX on your watchlist
- Every PCVX Form 4 filing on record
- Up to 3 months of PCVX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
